Women with polycystic ovary syndrome (PCOS) are more susceptible to metabolic dysfunction, especially glucose impairment. Previous studies have considered prediabetes (pre‐DM) and diabetes mellitus (DM) as single‐point outcomes without accounting for the transition states. This study aimed to explore the transition bet...
Maryam Mousavi, M. Saei Ghare Naz, M. Noroozzadeh et al.· Endocrinology, Diabetes & Me...· 1 citation
Sleep disturbances are increasingly recognized in women with polycystic ovary syndrome (PCOS), but the evidence remains inconsistent. We conducted a meta‐analysis to evaluate objective sleep abnormalities and subjective sleep complaints in women with PCOS.
A. Tabashiri, Pourya Kanani, M. Saei Ghare Naz et al.· Health Science Reports· 0 citations
Endometriosis is frequently managed with hormonal suppression that can induce hypoestrogenism during a period when many patients are still accruing peak bone mass. This narrative review summarizes current clinical and mechanistic evidence on bone health in endometriosis and its treatments and discusses a preliminary co...
F. Motafeghi, M. Saei Ghare Naz, F. Ramezani Tehrani et al.· Frontiers in Global Women's...· 0 citations
Higher AMH may be protective against T2DM in older healthy women but indicates elevated metabolic risk in younger women with PCOS, suggesting that AMH may serve as a life‐course biomarker for metabolic risk stratification and personalized preventive strategies in women's healthcare.
F. Ramezani Tehrani, Maryam Mousavi, M. Saei Ghare Naz et al.· Endocrinology, Diabetes & Me...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.